C17,20-Lyase inhibitors I. Structure-based de novo design and SAR study of C17,20-lyase inhibitors
作者:Nobuyuki Matsunaga、Tomohiro Kaku、Fumio Itoh、Toshimasa Tanaka、Takahito Hara、Hiroshi Miki、Masahiko Iwasaki、Tetsuya Aono、Masuo Yamaoka、Masami Kusaka、Akihiro Tasaka
DOI:10.1016/j.bmc.2004.02.007
日期:2004.5
Novel nonsteroidal C(17,20)-lyase inhibitors were synthesized using de novo design based on its substrate, 17 alpha-hydroxypregnenolone, and several compounds exhibited potent C(17,20)-lyase inhibition. However, in vivo activities were found to be short-lasting, and in order to improve the duration of action, a series of benzothiophene derivatives were evaluated. As a result, compounds 9h, (S)-9i,
新型非甾体类C(17,20)-裂合酶抑制剂是基于其底物,17α-羟基孕烯醇酮使用从头设计合成的,几种化合物均表现出有效的C(17,20)-裂合酶抑制作用。然而,发现体内活性是持久的,并且为了改善作用的持续时间,评估了一系列苯并噻吩衍生物。结果,鉴定出具有纳摩尔酶抑制(IC(50)= 4-9 nM)和9e(IC(50)= 27 nM)的化合物9h,(S)-9i和9k具有强大的体内功效,延长行动时间。证明体内功效的关键结构决定因素是苯并噻吩环上的5-氟基团和4-咪唑基部分。9k和17α-羟基孕烯醇酮的叠加显示了它们的结构相似性,并使药理学结果合理化。此外,选定的化合物也被鉴定为具有20-30 nM的IC(50)值的人类酶的有效抑制剂。